Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.35
0.011.12%
At Close: -
$1.34
-0.01-1.07%
After Hours: 7:16 AM EDT
15 minutes delayed
Comments
Loading...
Spero Therapeutics (SPRO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Spero Therapeutics (NASDAQ:SPRO) Stock Quotes, Forecast and News Summary
Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
| Open | $1.36 |
| Close | $1.36 |
| Volume / Avg. | 106.24K / 114.12K |
| Day Range | $1.33 - $1.37 |
| 52 Wk Range | 0.99 - 1.89 |
| Market Cap | $72.45M |
| P/E Ratio | 3.94 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 0.92% |
| Days to Cover | 3.04 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Spero Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, develo...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Spero Therapeutics (SPRO) stock?
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Who are Spero Therapeutics (SPRO) competitors?
Other companies in Spero Therapeutics’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Intensity Therapeutics (NASDAQ:INTS), Immuneering (NASDAQ:IMRX) and Armata Pharmaceuticals (AMEX:ARMP).
What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?
Spero Therapeutics has a consensus price target of $5.67.
What is the current price for Spero Therapeutics (SPRO)?
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.3405 last updated September 19, 2024 at 7:16 AM EDT.
Does Spero Therapeutics (SPRO) pay a dividend?
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?
Spero Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
Is Spero Therapeutics (SPRO) going to split?
There is no upcoming split for Spero Therapeutics.
What sector and industry does Spero Therapeutics (SPRO) operate in?
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.